When was ScubaTx founded?

ScubaTx was founded in 2020 and raised its 1st funding round 3 years after it was founded.

Where is ScubaTx located?

ScubaTx is headquartered in Newcastle Upon Tyne, United Kingdom. It is registered at LAKEHOUSE,MARKET HILL,ROYSTON,ENGLAND,SG8 9JN.

How many employees does ScubaTx have?

As of Feb 28, 2025, the latest employee count at ScubaTx is 7.

Is ScubaTx a funded company?

ScubaTx is a funded company, having raised a total of $3.71M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 15, 2023.

When was the latest funding round of ScubaTx?

ScubaTx's latest funding was a $***** Seed round on Sep 03, 2024, with participation from 1 investor.

Where does ScubaTx rank among its competitors?

ScubaTx ranks 10th amongst 34 active competitors, of which 11 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Bridge to Life, which secured $110M in Aug, 2026.

Who are the top competitors of ScubaTx?

ScubaTx's top competitors include OrganOx, TransMedics and Bridge to Life. Among them, Bridge to Life secured the most recent funding round in August, 2026.

ScubaTx - 2026 Company Profile, Team, Funding, Competitors & Financials

ScubaTx is a seed company based in Newcastle Upon Tyne (United Kingdom), founded in 2020 by Toby Clark, Toby Clark and William Scott. It operates as a Developer of organ preservation technology for transport and medical transplantation. ScubaTx has raised $3.71M in funding from Praetura Ventures. The company has 34 active competitors, including 11 funded and 6 that have exited. Its top competitors include companies like OrganOx, TransMedics and Bridge to Life.

Company Details

Developer of organ preservation technology for transport and medical transplantation. This system utilizes advanced temperature control and oxygenation to maintain organ viability. The technology includes reusable base units and organ-specific disposable cassettes designed for heart, kidney, liver, lung, and pancreas preservation. By employing persufflation, the platform delivers oxygen to organs during storage to minimize cellular damage and mitigate inflammation. This method replaces traditional cold storage techniques to extend the duration of tissue viability before surgical procedures.

Website: www.scubatx.com/
Registered Address: LAKEHOUSE,MARKET HILL,ROYSTON,ENGLAND,SG8 9JN

Key Metrics

Founded Year

2020

Location

Newcastle Upon Tyne, United Kingdom

Stage

Seed

Total Funding

$3.71M in 3 rounds

Latest Funding Round

Seed, Sep 03, 2024, $*****

Investors

Praetura Ventures & 3 more

Ranked

10^th among 34 active competitors

Employee Count

7 as on Feb 28, 2025

Similar Companies

OrganOx & 40 more

View ScubaTx's full profile

ScubaTx is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SCUBATX LIMITED CIN: 12447525 , United Kingdom, Active	Feb 05, 2020	-	7 (As on Feb 28, 2025)

ScubaTx has raised a total funding of $3.71M over 3 rounds. Its first funding round was on May 15, 2023. Its latest funding round was a Seed round on Sep 03, 2024 for $*****. 1 investor participated in its latest round. ScubaTx has 4 institutional investors.

Here is the list of recent funding rounds of ScubaTx:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 03, 2024	8065956	Seed	8837130	1889057	7537062	7627006
May 15, 2023	5509419	Seed	9004781	5470332	3712870	3986111
May 15, 2023	4209204	Grant (prize money)	3515306	1236181	7605942	Ukri

Access funding benchmarks and valuations. Sign up today!

View details of ScubaTx's funding rounds and investors

The founders of ScubaTx are Toby Clark, Toby Clark and William Scott.

Here are the details of ScubaTx's key team members:

Toby Clark: Chief Financial Officer / Co-Founder of ScubaTx and founder of 1 other company.
Toby Clark: Chief Financial Officer / Co-Founder of ScubaTx and founder of 1 other company.
William Scott: Founder of ScubaTx.
Phil Andrews: Co-Founder of ScubaTx.

View details of ScubaTx's Founder profiles and Board Members

ScubaTx's employee count trend

ScubaTx has 7 employees as of Feb 25. Here is ScubaTx's employee count trend over the years:

Uncover ScubaTx's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ScubaTx include OrganOx, TransMedics and Bridge to Life. Here is the list of Top 10 competitors of ScubaTx, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	OrganOx 2008, Oxford (United Kingdom), Acquired	Provider of a storage and transport system for harvested organs	$45.4M	Health Quest Capital, BGF & 61 others	75/100
2nd	TransMedics 1998, Andover (United States), Public	Developer of organ transplantation technology	$266M	Kleiner Perkins, Foundation Capital & 19 others	67/100
3rd	Bridge to Life 2012, Duluth (United States), Series C	Provider of cold storage solutions for the preservation of organ transplants	$167M	Perceptive Advisors, Soleus Capital & 2 others	58/100
4th	Paragonix Technologies 2010, Boston (United States), Acquired	Organ preservation technology improving transplant outcomes with digital tracking and clinical support	$25.1M	Signet Healthcare Partners, Massachusetts Life Sciences Center ... & 1 others	57/100
5th	Vascular Perfusion 2016, San Antonio (United States), Series D	Developer of a device for organ preservation	$152M	Military Health, Capital Factory	53/100
6th	Until Labs 2021, San Francisco (United States), Series A	Developer of reversible cryopreservation systems for human organs and tissues	$100M	Founders Fund, Lux Capital & 1 others	45/100
7th	XVIVO 1998, Gothenburg (Sweden), Public	Provider of organ preservation technologies and services. It offers machine perfusion technologies for kidneys, livers, and lungs, and a solution for cold static storage of lungs. The company also provides organ recovery and perfusion services. These technologies aim to increase organ utilization, extend preservation time, enable organ assessment, and improve transplant outcomes. A platform for sharing knowledge and experiences related to organ perfusion is also offered.	-	Europa	45/100
8th	ADVITOS 2005, Munich (Germany), Series B	Provider of multi-organ support systems	$23.8M	Credit Mutuel Equity, EIC Fund & 13 others	43/100
9th	Organ Recovery Systems 1998, Itasca (United States), Funding Raised	Organ preservation products and services improving transplant outcomes for patients	-	HHS	38/100
10th	ScubaTx 2020, Newcastle Upon Tyne (United Kingdom), Seed	Developer of organ preservation technology for transport and medical transplantation	$3.71M	Praetura Ventures, Conduit Connect & 2 others	36/100